Company Filing History:
Years Active: 2023
Title: Francesco Manoni: Innovator in PRMT5 Inhibitors
Introduction
Francesco Manoni is a notable inventor based in Newbury Park, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of PRMT5 inhibitors. His work focuses on creating compounds that can potentially treat various proliferative, metabolic, and blood disorders.
Latest Patents
Francesco holds 1 patent related to his innovative work. His patent describes novel PRMT5 inhibitors of Formula I and pharmaceutically acceptable salts thereof. These compounds are designed to inhibit PRMT5 activity, which is crucial for addressing specific health conditions.
Career Highlights
Francesco is associated with Amgen Inc., a leading biotechnology company known for its commitment to developing innovative therapies. His role at Amgen has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Francesco has collaborated with talented individuals such as Shon Booker and Matthew Paul Bourbeau. These partnerships have enhanced the research and development process, leading to advancements in their respective fields.
Conclusion
Francesco Manoni's work in developing PRMT5 inhibitors showcases his dedication to innovation in the pharmaceutical industry. His contributions have the potential to make a significant impact on the treatment of various disorders.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.